SCHEMBL16039617

SCHEMBL16039617

COC(=O)c1ccc(C(Cl)=NNc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
BLM P54132 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
EPAS1 Q99814 1/20 0.50
EPHX2 P34913 4/20 0.47
FAAH O00519 2/20 0.47
TRPV1 Q8NER1 3/20 0.47
RAPGEF3 O95398 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.46
NPC1 O15118 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16039616 1.00 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL16084137 1.00 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL16039450 0.88 EPHX2 (0.58) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL16039451 0.88 EPHX2 (0.58) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL4549465 0.83 MAPT (0.49) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL514352 0.81 CA1 (0.64) MAPTSMN1; SMN2TDP1MEN1KMT2A
SCHEMBL16039766 0.81 MAPT (0.47) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL4549453 0.81 MAPT (0.47) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL16039803 0.78 RAB9A (0.62) MAPTSMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL16039805 0.78 RAB9A (0.62) MAPTSMN1; SMN2ALDH1A1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9212150-B2 Process for the preparation of certain triaryl pesticide intermediates DOW AGROSCIENCES LLC (US) 2015-12-15 US disclosed
WO-2014163933-A1 PROCESS FOR PREPARATION OF TRIARYL PESTICIDE INTERMEDIATE DOW AGROSCIENCES LLC (US) 2014-10-09 WO disclosed
US-20140275557-A1 PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL PESTICIDE INTERMEDIATES DOW AGROSCIENCES LLC (US) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275557-A1 PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL PESTICIDE INTERMEDIATES DDT, POR, CYP4F3 MAPT 4059/4885SMN1; SMN2 4693/4885ALDH1A1 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.